RE:TARGET OF 1.28 HIT.....You're getting too myopic in your analysis.
100% growth + accretive acquisitions in the pipeline...for the next 2-3 years
The cost advantage of the current offerings open up a whole host of 'new' customers.
...with the kicker of a 'step-change' in MRI technology coming for scanning of humans...at a significant cost advantage to the 'old' technology.
Big picture chart:
3 Year rangebound between $0.80 down to $0.35. ($0.45)
Stepping up above old highs by $0.45 to the $1.25 +
3 year return: 50-60%...to as much as 250% (depending on the worst or best entry level)
Projected 3 year return from here?
A repeat performance.
Conclusion: Park some 'in storage' for awhile and let 'Sean and the team' keep moving the needle.
https://www.nanalysis.com/management